Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial. uri icon

authors

  • Singh, Siddharth
  • Hwang, Caroline
  • Sprung, Brandon
  • Gaidos, Jill K J
  • Mattar, Mark C
  • Rubin, David T
  • Hashash, Jana G
  • Metwally, Mark
  • Ali, Tauseef
  • Ma, Christopher
  • Hoentjen, Frank
  • Nguyen, Jasmine D
  • Narula, Neeraj
  • Bessissow, Talat
  • Rosenfeld, Greg
  • McCurdy, Jeffrey D
  • Ananthakrishnan, Ashwin N
  • Cross, Raymond K
  • Rodriguez Gaytan, Jorge R
  • Gurrola, Emily-Sophinie
  • Patel, Sagar
  • Siegel, Corey A
  • Fudman, David I
  • Melmed, Gil Y
  • Weaver, S Alandra
  • Power, Sydney
  • Zou, Guangyong
  • Jairath, Vipul
  • Hou, Jason K
  • Gerich, Mark E
  • Samir K. Shah, MD, MPH
  • Hudesman, David
  • McConnell, Ryan A
  • Lukin, Dana J
  • Flynn, Ann D

publication date

  • March 31, 2025